| Nov 19 |
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference
|
| Nov 14 |
Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data
|
| Nov 14 |
Meiji Seika Pharma Announces Investment in ARCALIS, Inc.
|
| Nov 11 |
Arcturus gets FDA clearance for H5N1 avian flu vaccine study
|
| Nov 11 |
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial
|
| Nov 9 |
Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 8 |
Q3 2024 Arcturus Therapeutics Holdings Inc Earnings Call
|
| Nov 8 |
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ...
|
| Nov 8 |
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2024 Earnings Call Transcript
|
| Nov 7 |
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates
|
